Delivery Order SPE2DE21D7020-SPE2D625F1FDX
- Not listed
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order valued at $92,950 to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This delivery order, with a fixed-price contract structure that includes economic price adjustment provisions, was awarded on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This award represents a continuation...
- The Defense Health Agency's Medical Supply Chain issued a delivery order valued at $92,950 on August 11, 2025, to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by August 18, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The contract utilizes no set-aside designation, allowing the award to be made through open competition. As a...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, valued at approximately $52K with a fixed-price contract that includes economic price adjustment provisions. The delivery order was issued on September 8, 2025, with an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No small business set-aside was utilized for...
- The Defense Health Agency's Medical Supply Chain awarded a $67.6K delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 18, 2025. This delivery order was issued without a set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts,...
- Boston Scientific Corp was awarded a $84.5K delivery order by the Defense Health Agency's Medical Supply Chain on September 12, 2025, for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. The contract employs fixed-price pricing with economic price adjustment terms and carries no set-aside designation, indicating open competition. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts, where the company...
- The U.S. Defense Health Agency's Medical Supply Chain awarded a $45,000 fixed-price delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, effective through August 14, 2025. This delivery order, which includes economic price adjustment provisions, represents Boston Scientific's continued supply of advanced cardiac intervention technologies to the federal healthcare system. The award was made without a set-aside designation, allowing Boston Scientific to...
- Boston Scientific Corp has been awarded a delivery order contract valued at $58,675 for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. The award was made by the Defense Health Agency's Medical Supply Chain on September 12, 2025, with no set-aside designation. The contract utilizes fixed-price pricing with economic price adjustment terms and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order...
- Boston Scientific Corp has been awarded a delivery order valued at $48.8K for the FARAPULSE Pulsed Field Ablation System under a fixed-price contract with economic price adjustment provisions. The contract, awarded on June 2, 2025, with an ultimate completion date of June 10, 2025, is being funded through the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a continuation of Boston...
- Boston Scientific Corp was awarded a delivery order valued at $92,950.00 for the FARAPULSE Pulsed Field Ablation System on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract is fixed-price with economic price adjustment and carries no set-aside designation. The award was funded through the Defense Health Agency's Medical Supply Chain and will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. The FARAPULSE system represents a...
- Boston Scientific Corp was awarded a $49.8K fixed-price delivery order with economic price adjustment on July 11, 2025, for the FARAPULSE Pulsed Field Ablation System. The contract is funded through the Defense Health Agency's Medical Supply Chain program and extends through July 18, 2025. The system will be delivered to Marlborough, Massachusetts, where Boston Scientific maintains its primary operations. This delivery order is not set aside for any specific business classification and...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1FDXDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp valued at $16,900 for the FARAPULSE Pulsed Field Ablation System. The contract, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. Performance will be conducted at Boston Scientific's Marlborough, Massachusetts facility, where the company manufactures advanced cardiovascular and medical device technologies. This delivery order represents a continuation of Boston Scientific's role as a critical supplier of specialized medical equipment to federal healthcare agencies. As a global medical technology leader, Boston Scientific maintains an extensive portfolio of federal contracts with the Defense Health Agency, Department of Veterans Affairs, and Defense Logistics Agency, supplying innovative medical devices ranging from implantable cardioverter defibrillators to diagnostic tools. The company holds a single-award Blanket Purchase Agreement with DHA valued at $750,000 through March 2030 for radiation treatment devices, positioning it as a primary vendor for advanced medical technologies within the federal healthcare system. This FARAPULSE delivery order aligns with Boston Scientific's established capabilities in providing cutting-edge cardiovascular intervention solutions to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 8/18/25 |